TR201010860A2 - Production method for cefdinir formulations. - Google Patents

Production method for cefdinir formulations.

Info

Publication number
TR201010860A2
TR201010860A2 TR2010/10860A TR201010860A TR201010860A2 TR 201010860 A2 TR201010860 A2 TR 201010860A2 TR 2010/10860 A TR2010/10860 A TR 2010/10860A TR 201010860 A TR201010860 A TR 201010860A TR 201010860 A2 TR201010860 A2 TR 201010860A2
Authority
TR
Turkey
Prior art keywords
production method
cefdinir
formulations
cefdinir formulations
processes
Prior art date
Application number
TR2010/10860A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TR2010/09167A external-priority patent/TR201009167A2/en
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/10860A priority Critical patent/TR201010860A2/en
Priority to PCT/TR2011/000254 priority patent/WO2012060789A2/en
Priority to PCT/TR2011/000258 priority patent/WO2012060793A2/en
Publication of TR201010860A2 publication Critical patent/TR201010860A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Mevcut buluş, aktif ajan olarak sefdinir içeren formülasyonların hazırlanmasında kullanılacak proseslere ve bu prosesle elde edilecek farmasötik bileşimlere ilişkindir.The present invention relates to processes to be used in the preparation of formulations containing cefdinir as an active agent and pharmaceutical compositions to be obtained by this process.

TR2010/10860A 2010-11-05 2010-12-24 Production method for cefdinir formulations. TR201010860A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/10860A TR201010860A2 (en) 2010-11-05 2010-12-24 Production method for cefdinir formulations.
PCT/TR2011/000254 WO2012060789A2 (en) 2010-11-05 2011-11-03 Production method for cefdinir formulations
PCT/TR2011/000258 WO2012060793A2 (en) 2010-11-05 2011-11-03 Process for the preparation of cefdinir formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/09167A TR201009167A2 (en) 2010-11-05 2010-11-05 Pharmaceutical granules containing cephalosporin.
TR2010/10860A TR201010860A2 (en) 2010-11-05 2010-12-24 Production method for cefdinir formulations.

Publications (1)

Publication Number Publication Date
TR201010860A2 true TR201010860A2 (en) 2012-05-21

Family

ID=45607339

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/10860A TR201010860A2 (en) 2010-11-05 2010-12-24 Production method for cefdinir formulations.

Country Status (2)

Country Link
TR (1) TR201010860A2 (en)
WO (2) WO2012060789A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836918B (en) 1982-09-30 1984-05-30 Fujisawa Pharmaceutical Co 7-substituted-3-vinyl-3-cephem compounds and processes for the production of the same
DE3887179T2 (en) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmaceutical composition, pharmaceutical granules and process for their preparation.
EA200500213A1 (en) * 2002-07-16 2005-08-25 Рэнбакси Лабораториз Лимитед DISPENSABLE TABLETS FOR ORAL APPOINTMENT
CA2393614C (en) * 2002-07-19 2003-09-30 Abbott Laboratories Antibacterial clarithromycin compositions and processes for making the same
CN1767818A (en) * 2004-05-31 2006-05-03 三亚药品株式会社 Dispersible tablet comprising beta lactam antibiotics and process for preparing the same
WO2007058397A1 (en) * 2005-11-17 2007-05-24 Gl Pharmtech Corp. A dispersible tablet comprising the mixture of amoxicillin and clavulanic acid or its salts and processes for preparing the same

Also Published As

Publication number Publication date
WO2012060793A3 (en) 2012-06-28
WO2012060789A2 (en) 2012-05-10
WO2012060789A3 (en) 2012-06-28
WO2012060793A2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
MX2018015892A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2019001253A (en) Protein-active agent conjugates and method for preparing the same.
UA113651C2 (en) MACROCYCLIC PURINS FOR TREATMENT OF Viral INFECTIONS
EA201290980A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBURONIC ACID
MX2015005944A (en) Microbial strains, compositions, and methods for increasing available phosphate for plants.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
GB201205769D0 (en) Methods for preparing samples for nucleic acid amplification
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
BR112012032248A2 (en) 5-ethyl-2- {4 - [- 4- (-4-tetrazol-1-yl-phenoxymethyl) -thiazol-2-yl] -piperidin-1-yl} -pyrimidine compositions
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
MX358132B (en) Thrombin solution and methods of use thereof.
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
BR112015031820A2 (en) compound, pharmaceutical composition, intermediate, process for preparing a compound and methods
WO2011093831A3 (en) Effervescent formulations comprising cefprozil as active agent
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
EA201492280A1 (en) STABLE PEXIGANANE COMPOSITION
IN2014DN10135A (en)
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201010860A2 (en) Production method for cefdinir formulations.
MX2014006597A (en) Mandelic acid condensation polymers.
WO2012060791A3 (en) Production method for pharmaceutical compositions comprising cefdinir
TR201104864A2 (en) Water-soluble formulations containing dexketoprofen.
TR201009165A2 (en) Tablets containing cefdinir